News
Roche has found redemption in a precision medicine approach following an earlier Tecentriq trial flop in a broader bladder ...
For patients undergoing a radical cystectomy, staying active before and after surgery is key, Dr. Janet Kukreja explained.
By combining high-res imaging tools with light-absorbing nanostars, researchers can more precisely treat cancerous tumors.
The implications are huge. Bladder cancer ranks as the sixth most common cancer in the U.S., affecting around 80,000 people ...
Biomedical engineers at Duke University have developed a method to more precisely heat up gold nanoparticles to target and ...
An expert discusses how non-muscle invasive bladder cancer (NMIBC) creates a significant clinical and financial burden with up to 60% recurrence rates, affecting an estimated 85,000 new patients ...
An expert discusses how non-muscle invasive bladder cancer (NMIBC) is a localized form of urothelial cell carcinoma that primarily affects older men with smoking as the primary risk factor, requiring ...
In Q2 2025, ImmunityBio, Inc. (NASDAQ:IBRX) reported a 60% revenue growth quarter-over-quarter, reaching $26.4 million and a ...
A new drug delivery system has shown remarkable success in treating a common form of bladder cancer that had stopped ...
The biomedical bond between people and dogs is not new; veterinarians have long treated their canine patients with drugs developed for use in people, and doctors have relied on dogs ...
Here is our list of the 12 best healthcare stocks to buy under $30. ImmunityBio, Inc. (NASDAQ:IBRX) is among the best ...
The press conference that University of Colorado Boulder football coach Deion Sanders held at the end of July brought to light the serious health issues that he has been dealing with. Sanders, known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results